Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd
sales@dingminpharma.com
86-311-67260775
Modell nr: CAS 1421373-65-0
Märke: DM
Grade Standard: Medicine Grade
Type: Chemical Reagent
State: Solid
Volatile: Not Volatile
Förpackning: Dubbel PE med aluminiumfoliepåse
Produktivitet: 100kg/month
Transportfordon: Ocean,Air
Hemorten: Hebei, Kina
Stödja: 100kg/month
Certifikat: ISO9001
Hamn: Shanghai
Betalning Typ: L/C,T/T,Paypal
Incoterm: FOB,CIF
| Item Name | AZD-9291/ Osimertinib |
| CAS NO | 1421373-65-0 |
| Function |
Osimertinib (previously known as mereletinib or AZD9291) is a third-generation epidermal growth factor receptor tyrosine kinase inhibitor drug.
Osimertinib is a Kinase Inhibitor. The mechanism of action of osimertinib is as a Kinase Inhibitor, and Cytochrome P450 3A Inhibitor, and Cytochrome P450 3A4 Inducer, and Cytochrome P450 1A2 Inducer, and Breast Cancer Resistance Protein Inhibitor.
Osimertinib used in the therapy of selected forms of advanced non-small cell lung cancer (NSCLC). Osimertinib is associated with a moderate rate of serum aminotransferase elevations during therapy and rare instances of clinically apparent acute liver injury. |
| Apparence | White Powder |
| Package | Aluminum Bag;Drums;Paper Box Outside |
| Shipment | FedEx;DHL;UPS;TNT;EMS;Sea;Air. |
| Payment | Western Union;T/T;Trade Assurance;L/C |
| Warranty | 2 Years |
Vi är den professionella tillverkaren av API, råmaterial farma, farmaceutiska mellanprodukter, aktiva farmaceutiska ingredienser, agrokemiska mellanprodukter och fina kemikalier. Med bästa kvalitet och konkurrenskraftiga pris.
Produktkategorier : API: er och mellanprodukter > Apispulver
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Contact Now